Lv31
310 积分 2024-12-03 加入
The recent advance of Interleukin-1 receptor associated kinase 4 inhibitors for the treatment of inflammation and related diseases
7天前
已完结
Interleukin-1 Receptor-Associated Kinase 4 (IRAK4) Degraders for Treating Inflammatory Diseases: Advances and Prospects
10天前
已完结
IRAK4: potential therapeutic target for airway disease exacerbations
10天前
已完结
Negative regulator IL-1 receptor 2 (IL-1R2) and its roles in immune regulation of autoimmune diseases
11天前
已完结
Molecular mechanisms of regulation of IL-1 and its receptors
11天前
已完结
Advances in HER2-Targeted Therapies: From monoclonal antibodies to dual inhibitors developments in cancer treatment
19天前
已完结
The Lasting Impact of IL-2: Approaching 50 Years of Advancing Immune Tolerance, Cancer Immunotherapies, and Autoimmune Diseases
27天前
已完结
Elucidating CTLA-4’s role in tumor immunity: a comprehensive overview of targeted antibody therapies and clinical developments
1个月前
已完结
The CD27–CD70 pathway and pathogenesis of autoimmune disease
1个月前
已完结
CD28 co-stimulation: novel insights and applications in cancer immunotherapy
1个月前
已完结
皖公网安备34019202002308
